# Icatibant

NDC: 0093-3066
Generic name: Icatibant
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190715

FDA application: ANDA210118

## Active ingredients

- ICATIBANT ACETATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-3066"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-3066
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=402a20e0-d1e2-4a24-ae1d-f2ff6d8fa7b3